Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Fisher & Paykel Healthcare Corporation Announces Withdrawal of US ITC Complaint

17 May 2017  |  09:30:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Withdrawal of US ITC Complaint Against FPH

Fisher & Paykel Healthcare Corporation announced that ResMed has filed a motion with the US International Trade Commission (ITC) to terminate the current investigation by withdrawing its complaint against the Company. Following a pre-trial ruling by the US ITC Administrative Law Judge concerning ResMed's evidence of domestic industry, ResMed has notified the Company, that it has filed an unopposed motion for termination of the investigation by withdrawal of the complaint. The withdrawal of the complaint with the US ITC does not impact the patent litigation proceedings involving the Company and ResMed in the US District Court, Germany, the UK and NZ.

Please click here for full details

See more ASX300 News Announcements